Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D06ALB
|
|||
Former ID |
DNC000288
|
|||
Drug Name |
BCH-2763
|
|||
Synonyms |
UNII-2Y77S7IT1P; 2Y77S7IT1P; BCH 2763; 204641-27-0
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Thrombosis [ICD-11: DB61-GB90; ICD-10: I80-I82] | Terminated | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C64H93N11O16
|
|||
Canonical SMILES |
CCC(C)C(C(=O)N1CCCC1C(=O)N(C(CC(C)C)C(=O)O)C(=O)CCCCNC(=O)C2CCCN2C(=O)C(CC3=CC=CC=C3)N)NC(=O)C4CCCN4C(=O)C(CCC(=O)O)NC(=O)C(CC5=CC=CC=C5)NC(=O)C(CC(=O)O)NC(=O)CCCCN
|
|||
InChI |
1S/C64H93N11O16/c1-5-40(4)55(71-59(85)48-24-17-33-73(48)61(87)44(28-29-53(78)79)69-56(82)45(37-42-21-10-7-11-22-42)70-57(83)46(38-54(80)81)68-51(76)26-12-14-30-65)63(89)74-34-18-25-49(74)62(88)75(50(64(90)91)35-39(2)3)52(77)27-13-15-31-67-58(84)47-23-16-32-72(47)60(86)43(66)36-41-19-8-6-9-20-41/h6-11,19-22,39-40,43-50,55H,5,12-18,23-38,65-66H2,1-4H3,(H,67,84)(H,68,76)(H,69,82)(H,70,83)(H,71,85)(H,78,79)(H,80,81)(H,90,91)/t40-,43+,44-,45-,46-,47-,48-,49-,50-,55-/m0/s1
|
|||
InChIKey |
VKIPOMGKUAJAEY-GEPLSBMPSA-N
|
|||
CAS Number |
CAS 204641-27-0
|
|||
PubChem Compound ID | ||||
PubChem Substance ID |
602112, 7979525, 11121773, 11122253, 11362949, 11365511, 11368073, 11371069, 11371070, 11373674, 11376235, 16003641, 26756847, 43128595, 47944494, 48170149, 48413940, 49857450, 50061803, 50078012, 50111452, 53788333, 56231459, 57318714, 77099929, 92310124, 99301036, 99302556, 104060153, 104352924, 117585558, 127936552, 134339750, 134339752, 134339755, 134339756, 134340176, 135030613, 139421944, 160661376, 175267735, 184589588, 223653355, 226888611, 241182192, 241375264, 242084562, 249617260, 250132850, 252344670
|
References | Top | |||
---|---|---|---|---|
REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800007017) | |||
REF 2 | BCH-2763, a novel potent parenteral thrombin inhibitor, is an effective antithrombotic agent in rodent models of arterial and venous thrombosis--comparisons with heparin, r-hirudin, hirulog, inogatran and argatroban. Thromb Haemost. 1998 Feb;79(2):431-8. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.